Back
Also listed as
DGWPF
OTC
Day Range
$109.51
$109.51
52-Week Range
$58.15
$111.00
Volume
100
50D / 200D Avg
$99.68
/
$81.59
Prev Close
$109.51
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 15.8 | 0.2 |
| P/B | 1.4 | 3.0 |
| ROE % | 8.8 | 3.6 |
| Net Margin % | 4.0 | 3.8 |
| Rev Growth 5Y % | 1.1 | 9.9 |
| D/E | 0.3 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$10.78
$10.45 – $11.47
|
3.87B | 1 |
| FY2028 |
$10.18
$9.87 – $10.83
|
3.76B | 1 |
| FY2027 |
$8.64
$8.37 – $9.18
|
3.74B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-24 | N/A | $5.93 | — |
| 2025-10-29 | N/A | $2.24 | — |
| 2025-07-29 | N/A | $0.71 | — |
| 2025-04-30 | N/A | -$0.13 | — |
| 2025-01-15 | N/A | $4.13 | — |
| 2024-10-29 | N/A | $0.84 | — |
| 2024-07-25 | N/A | $1.53 | — |
| 2024-04-25 | N/A | $0.41 | — |
Dividend History
7 yr streakYield
0.03%
Payout Ratio
0.27%
Growth (3Y)
124.46%
Growth (5Y)
58.99%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 11, 2026 | May 13, 2026 | $1.94 | 1.77% |
| May 13, 2025 | May 14, 2025 | $2.27 | 3.39% |
| May 09, 2024 | May 13, 2024 | $1.94 | 3.78% |
| May 08, 2023 | May 10, 2023 | $0.21 | 0.47% |
| May 09, 2022 | May 11, 2022 | $0.20 | 0.42% |
| May 10, 2021 | May 12, 2021 | $0.23 | 0.25% |
| Oct 01, 2020 | Oct 05, 2020 | $0.22 | 0.25% |
| May 13, 2019 | May 15, 2019 | $0.21 | 0.40% |
| May 07, 2018 | May 09, 2018 | $0.55 | 0.75% |
| May 11, 2017 | May 15, 2017 | $0.21 | 0.20% |
| Apr 28, 2016 | Apr 28, 2016 | $0.22 | 0.21% |
| May 04, 2015 | May 04, 2015 | $1.55 | 1.49% |
| May 12, 2014 | May 12, 2014 | $1.14 | 0.92% |
| May 06, 2013 | May 06, 2013 | $1.20 | 1.26% |
| May 07, 2012 | May 07, 2012 | $0.25 | 0.26% |
| May 09, 2011 | May 09, 2011 | $1.70 | 2.39% |
| May 10, 2010 | May 10, 2010 | $0.51 | 0.72% |
| May 11, 2009 | May 11, 2009 | $0.48 | 0.67% |
| May 12, 2008 | May 12, 2008 | $0.85 | 1.20% |
| May 14, 2007 | May 14, 2007 | $0.74 | 1.05% |
Key Takeaways
Revenue grew 1.12% annually over 5 years — modest growth
Debt/Equity of 0.25 — conservative balance sheet
Generating 166.44M in free cash flow
PEG of 0.76 suggests growth is underpriced
Cash machine — converts 119.36% of earnings into free cash flow
Capital efficient — spends only 2.06% of revenue on capex
Growth
Revenue Growth (5Y)
1.12%
Revenue (1Y)3.25%
Earnings (1Y)12.09%
FCF Growth (3Y)17.06%
Quality
Return on Equity
8.82%
ROIC8.80%
Net Margin4.01%
Op. Margin6.84%
Safety
Debt / Equity
0.25
Current Ratio2.03
Interest Coverage10.42
Valuation
P/E Ratio
15.84
Forward P/E14.23
P/B Ratio1.36
EV/EBITDA9.79
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.25% | Revenue Growth (3Y) | 1.57% |
| Earnings Growth (1Y) | 12.09% | Earnings Growth (3Y) | 12.37% |
| Revenue Growth (5Y) | 1.12% | Earnings Growth (5Y) | -2.49% |
| Profitability | |||
| Revenue (TTM) | 3.48B | Net Income (TTM) | 139.44M |
| ROE | 8.82% | ROA | 4.26% |
| Gross Margin | 43.52% | Operating Margin | 6.84% |
| Net Margin | 4.01% | Free Cash Flow (TTM) | 166.44M |
| ROIC | 8.80% | FCF Growth (3Y) | 17.06% |
| Safety | |||
| Debt / Equity | 0.25 | Current Ratio | 2.03 |
| Interest Coverage | 10.42 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | 0.27% |
| Dividend Growth (3Y) | 124.46% | Dividend Growth (5Y) | 58.99% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 15.84 | Forward P/E | 14.23 |
| P/B Ratio | 1.36 | P/S Ratio | 0.63 |
| PEG Ratio | 0.76 | Forward PEG | N/A |
| EV/EBITDA | 9.79 | Fwd EV/EBITDA | 7.39 |
| Forward P/S | 0.61 | Fwd Earnings Yield | 7.03% |
| FCF Yield | 7.54% | ||
| Market Cap | 2.21B | Enterprise Value | 2.33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.48B | 3.37B | 3.37B | 3.05B | 3.33B |
| Net Income | 139.44M | 124.41M | 110.43M | -64.56M | 154.23M |
| EPS (Diluted) | 7.44 | 6.61 | 5.89 | -3.44 | 7.16 |
| Gross Profit | 1.51B | 1.51B | 1.46B | 1.24B | 1.54B |
| Operating Income | 238.19M | 180.01M | 184.13M | -79.76M | 277.68M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.28B | 3.09B | 3.09B | 3.11B | 3.18B |
| Total Liabilities | 1.65B | 1.56B | 1.69B | 1.79B | 1.92B |
| Shareholders' Equity | 1.63B | 1.54B | 1.41B | 1.32B | 1.26B |
| Total Debt | 404.96M | 395.58M | 471.38M | 361.95M | 348.01M |
| Cash & Equivalents | 282.00M | 223.47M | 260.00M | 302.47M | 439.44M |
| Current Assets | 1.91B | 1.88B | 1.87B | 1.90B | 1.99B |
| Current Liabilities | 944.06M | 978.48M | 1.02B | 1.22B | 934.91M |